3 results match your criteria: "Ankara Etlik Zübeyde Hanım Women’s Health Research Center[Affiliation]"
J Obstet Gynaecol
October 2022
Department of Gynecologic Oncology, Ankara City Hospital, University of Health Sciences, Ankara, Turkey.
In this retrospective study, patients with epithelial gynaecologic cancer with pulmonary recurrence (PR) were evaluated from five national gynaecologic oncology clinics. Patients with a diagnosis of primary endometrial, ovarian/fallopian tube/peritoneal, cervical or vaginal/vulvar tumours who developed an initial PR were included in the study A total of 122 patients were included in the study. The median follow-up time after recurrence was 7.
View Article and Find Full Text PDFJ Turk Ger Gynecol Assoc
September 2022
Clinic of Obstetric and Gynecology, University of Health Sciences Turkey, Ankara Etlik Zübeyde Hanım Women’s Health Research Center, Ankara, Turkey
Objective: The objective of this study was to estimate the number of oocyte retrieval and cycle cancellation using follicle stimulating hormone (FSH) to anti-Mullerian hormone (AMH) ratio in poor prognosis patients undergoing intracytoplasmic sperm injection treatment.
Material And Methods: This retrospective study including fresh cycles was conducted in Zekai Tahir Burak Women’s Health Training and Research Hospital, between January 2015 and October 2018. Women aged between 24 and 44 years were recruited and the baseline serum hormone levels, FSH/AMH ratio, and the antral follicle count were recorded.
Eur J Clin Microbiol Infect Dis
September 2017
Infection Control Department, Saudi German Hospital Group, Jeddah, Saudi Arabia.
Risk assessment of central nervous system (CNS) infection patients is of key importance in predicting likely pathogens. However, data are lacking on the epidemiology globally. We performed a multicenter study to understand the burden of community-acquired CNS (CA-CNS) infections between 2012 and 2014.
View Article and Find Full Text PDF